Eventide Healthcare & Life Sciences Fund CLASS I SHARES (ETIHX) - Health fund with $1.66 Billion in assets. The fund allocates 25.74% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is CELLDEX THERAPEU at 2.65% of total assets. This is followed by MIRUM PHARMACEUT (3.60%) and VAXCYTE INC (2.94%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| CELLDEX THERAPEU | 2.65% | - | - |
| MIRUM PHARMACEUT | 3.60% | - | - |
| VAXCYTE INC | 2.94% | - | - |
| INSMED INC | 3.15% | - | - |
| AURA BIOSCIENCES | 2.59% | - | - |
| GUARDANT HEALTH | 4.46% | - | - |
| COLLEGIUM PHARMA | 2.85% | - | - |
| AXSOME THERAPEUT | 3.50% | - | - |
| SAREPTA THERAPEU | None | - | - |
| LEXEO THERAPEUTI | None | - | - |
| US BANK MMDA - USBGFS 9 | 2.51% | - | - |
| EVOLENT HEALTH-A | 2.74% | - | - |
| EXACT SCIENCES | 2.58% | - | - |
| CRINETICS PHARMA | 2.52% | - | - |
| VERONA PHAR-ADR | 4.41% | - | - |
| SCHOLAR ROCK HOL | 2.49% | - | - |
| BLUEPRINT MEDICI | 2.93% | - | - |
| CELCUITY INC | 4.00% | - | - |
| ALNYLAM PHARMACE | 3.42% | - | - |
| IRHYTHM TECHNOLO | 2.85% | - | - |
| KYMERA THERAPEUT | 2.89% | - | - |
| BETA BIONICS | 3.19% | - | - |
| BELITE BIO INC | 3.11% | - | - |
| IONIS PHARMACEUT | 2.69% | - | - |
| ABIVAX SA-ADR | 2.62% | - | - |